Fundraising Fox

Lou Lange

Investor

Strategic Advisory Board at Longwood Fund

About

Former Chair and CEO of CV Therapeutics, later acquired by Gilead.

Colleagues at Longwood Fund

Frequently asked questions

Who is Lou Lange?
Former Chair and CEO of CV Therapeutics, later acquired by Gilead.
Where does Lou Lange work?
Lou Lange is Strategic Advisory Board at Longwood Fund.